Related references
Note: Only part of the references are listed.NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models
Deepak K. Bhatt et al.
CEPHALALGIA (2013)
Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine
Peer Tfelt-Hansen et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
5-HT1B receptors inhibit glutamate release from primary afferent terminals in rat medullary dorsal horn neurons
I-S Choi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Management of Cluster Headache
Peer C. Tfelt-Hansen et al.
CNS DRUGS (2012)
MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of migraine
Stephen Silberstein
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Efficacy and Safety of MAP0004, Orally Inhaled DHE in Treating Migraines With and Without Allodynia
Stewart J. Tepper et al.
HEADACHE (2012)
Pathogenesis of Migraine: Role of Neuromodulators
Giovanni D'Andrea et al.
HEADACHE (2012)
Dihydroergotamine, Ergotamine, Methysergide and Sumatriptan - Basic Science in Relation to Migraine Treatment
Carl Dahlof et al.
HEADACHE (2012)
Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
Markus Farkkila et al.
LANCET NEUROLOGY (2012)
Basic mechanisms of migraine and its acute treatment
Lars Edvinsson et al.
PHARMACOLOGY & THERAPEUTICS (2012)
One Hundred Years of Migraine Research: Major Clinical and Scientific Observations From 1910 to 2010
Peer C. Tfelt-Hansen et al.
HEADACHE (2011)
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment
Anna Ferrari et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Calcitonin Gene-Related Peptide-Mediated Enhancement of Purinergic Neuron/Glia Communication by the Algogenic Factor Bradykinin in Mouse Trigeminal Ganglia from Wild-Type and R192Q Cav2.1 Knock-In Mice: Implications for Basic Mechanisms of Migraine Pain
Stefania Ceruti et al.
JOURNAL OF NEUROSCIENCE (2011)
Emerging migraine treatments and drug targets
Jes Olesen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model
K. Y. Chan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Preclinical pharmacological profile of the selective 5-HTIF receptor agonist lasmiditan
David L. Nelson et al.
CEPHALALGIA (2010)
Acute treatment of migraine with the selective 5-HTIF receptor agonist lasmiditan - A randomised proof-of-concept trial
Michel D. Ferrari et al.
CEPHALALGIA (2010)
Safety and Pharmacokinetics of NXN-188 After Single and Multiple Doses in Five Phase I, Randomized, Double-Blind, Parallel Studies in Healthy Adult Volunteers
David Vaughan et al.
CLINICAL THERAPEUTICS (2010)
Triptans for the Management of Migraine
Mollie M. Johnston et al.
DRUGS (2010)
Revisiting the Role of Ergots in the Treatment of Migraine and Headache
Eric P. Baron et al.
HEADACHE (2010)
Selective Inhibition of 5-HT7 Receptor Reduces CGRP Release in an Experimental Model for Migraine
Xiaojuan Wang et al.
HEADACHE (2010)
PRESYNAPTIC 5-HT1B RECEPTOR-MEDIATED SEROTONERGIC INHIBITION OF GLUTAMATE TRANSMISSION IN THE BED NUCLEUS OF THE STRIA TERMINALIS
J. -D. Guo et al.
NEUROSCIENCE (2010)
DIFFERENTIAL DISTRIBUTION OF CALCITONIN GENE-RELATED PEPTIDE AND ITS RECEPTOR COMPONENTS IN THE HUMAN TRIGEMINAL GANGLION
S. Eftekhari et al.
NEUROSCIENCE (2010)
5-HT1F Receptor Agonists: A New Treatment Option for Migraine Attacks?
Lars Neeb et al.
NEUROTHERAPEUTICS (2010)
CGRP Receptor Antagonism and Migraine
Lars Edvinsson et al.
NEUROTHERAPEUTICS (2010)
Cluster Headache: Diagnosis and Treatment
Rashmi Halker et al.
SEMINARS IN NEUROLOGY (2010)
Possible sites of action of the new calcitonin gene-related peptide receptor antagonists
Sajedeh Eftekhari et al.
Therapeutic Advances in Neurological Disorders (2010)
Brainstem and thalamic projections from a craniovascular sensory nervous centre in the rostral cervical spinal dorsal horn of rats
Y. Liu et al.
CEPHALALGIA (2009)
Therapeutic potential of novel glutamate receptor antagonists in migraine
Anna P. Andreou et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice
Alex Brenchat et al.
PAIN (2009)
The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs
Carlos M. Villalon et al.
PHARMACOLOGY & THERAPEUTICS (2009)
History of methysergide in migraine
P. J. Koehler et al.
CEPHALALGIA (2008)
History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward
P. C. Tfelt-Hansen et al.
CEPHALALGIA (2008)
The discovery and development of the triptans, a major therapeutic breakthrough
Patrick P. A. Humphrey
HEADACHE (2008)
Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system
Andrea Stephanie Link et al.
JOURNAL OF HEADACHE AND PAIN (2008)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
Release of glutamate and CGRP from trigeminal ganglion neurons:: Role of calcium channels and 5-HT1 receptor signaling
Yan Xiao et al.
MOLECULAR PAIN (2008)
Excessive acute migraine medication use and migraine progression
Marcelo E. Bigal et al.
NEUROLOGY (2008)
Pharmacological properties of a wide array of ergolines at functional alpha(1)-adrenoceptor subtypes
Tilo Gornemann et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
5-HT7 receptor-mediated dilatation in the middle meningeal artery of anesthetized rats
Jose A. Terron et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
The colocalization of CGRP receptor and AMPA receptor in the spinal dorsal horn neuron of rat: A morphological and electrophysiological study
Xing-Long Gu et al.
NEUROSCIENCE LETTERS (2007)
Recent advances in understanding migraine mechanisms, molecules and therapeutics
Peter J. Goadsby
TRENDS IN MOLECULAR MEDICINE (2007)
The role of synaptic ion channels in synaptic plasticity
Giannis Voglis et al.
EMBO REPORTS (2006)
Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: A migraine target?
Kevin G. Shields et al.
NEUROBIOLOGY OF DISEASE (2006)
Acute effects of sumatriptan on aortic blood pressure, stiffness, and pressure waveform
Floris H. M. Vanmolkot et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients
JL Bellamy et al.
HEADACHE (2006)
Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells
C Mahé et al.
NEUROPHARMACOLOGY (2005)
[H3]LY334370, a novel radioligand for the 5-HT1F receptor.: I.: In vitro characterization of binding properties
DB Wainscott et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2005)
Consensus statement:: Cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine
D Dodick et al.
HEADACHE (2004)
Calcitonin gene-related peptide and its role in migraine pathophysiology
U Arulmani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Ergotamine and dihydroergotamine: History, pharmacology, and efficacy
SD Silberstein et al.
HEADACHE (2003)
Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633
RB McCall et al.
CEPHALALGIA (2002)
An immunocytochemical investigation of human trigeminal nucleus caudalis:: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres
D Smith et al.
CEPHALALGIA (2002)
CGRP may play a causative role in migraine
LH Lassen et al.
CEPHALALGIA (2002)
Drug therapy: Migraine - Current understanding and treatment.
PJ Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT1B and 5-HT1D receptor antagonists and in situ hybridization
RWM van den Broek et al.
CEPHALALGIA (2002)
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment:: a meta-analysis of 53 trials
MD Ferrari et al.
LANCET (2001)
Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine
B Gomez-Mancilla et al.
CEPHALALGIA (2001)
Co-localization of 5-HT1B/1B/1F receptors and glutamate in trigeminal ganglia in rats
QP Ma
NEUROREPORT (2001)
Triptans in migraine - A comparative review of pharmacology, pharmacokinetics and efficacy
P Tfelt-Hansen et al.
DRUGS (2000)
Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels
AM VanDenBrink et al.
NEUROLOGY (2000)
Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches
JNJM de Hoon et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Current and emerging second-generation triptans in acute migraine therapy: A comparative review
D Deleu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2000)
A novel, potent, and selective 5-HT7 antagonist:: (R)-3-(2-(2-(4-methylpiperidin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)
PJ Lovell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
